The lungs serve the primary function of air-blood gas exchange in all mammals and in terrestrial vertebrates. Efficient gas exchange requires a large surface area that provides intimate contact between the atmosphere and the circulatory system. To achieve this, the lung contains a branched conducting system (the bronchial tree) and specialized air-blood gas exchange units (the alveoli). The conducting system brings air from the external environment to the alveoli and functions to protect the lung from debris that could obstruct airways, from entry of pathogens, and from excessive loss of fluids. The distal lung enables efficient exchange of gas between the alveoli and the conducting system and between the alveoli and the circulatory system. In this article, we highlight developmental and physiological mechanisms that specify, pattern, and regulate morphogenesis of this complex and essential organ. Recent advances have begun to define molecular mechanisms that control many of the important processes required for lung organogenesis; however, many questions remain. A deeper understanding of these molecular mechanisms will aid in the diagnosis and treatment of congenital lung disease and in the development of strategies to enhance the reparative response of the lung to injury and eventually permit regeneration of functional lung tissue.
INTRODUCTION
Lung development is commonly divided into five stages (embryonic, pseudoglandular, canalicular, saccular, and alveolar) (Figs. 1 and 2). The embryonic stage begins with the specification of progenitor cells in the foregut. Subsequent stages include morphogenesis of the proximal and distal conducting airways, formation of alveoli, and differentiation of cell types that are required for regionspecific functions of the lung, such as protection from foreign substances ( particles and pathogens), efficient movement of air into and out of the lung, and efficient gas exchange with the circulatory system (Thurlebeck 1995; Deutsch and Pinar 2002; Harpole and Aloia 2005; Joshi and Kotecha 2007; Warburton et al. 2010 ).
This review is intended to complement other reviews (Warburton et al. , 2010 Cardoso and Lu 2006; Maeda et al. 2007; Cardoso and Kotton 2008; Morrisey and Hogan 2010; Rawlins 2011; Rock and Hogan 2011) by highlighting the key signaling pathways that regulate communication between epithelium, mesenchyme, and mesothelium during the early stages of lung development.
EMBRYONIC ORIGINS OF THE LUNG
The embryonic foregut gives rise to the respiratory tract, esophagus, stomach, intestine, liver, gallbladder, and pancreas. Development of the respiratory tract is initiated at embryonic day 9-9.5 in the mouse (Balfour 1881; Ten Have-Opbroek 1981; Kaufman 1992) , 11-11.5 in the rat (Merei et al. 1997; Qi and Beasley 2000; Williams et al. 2003) , and 22 -26 in human (Dubreuil et al. 1936; Jeffrey 1998; Sadler 2010) . The first morphogenetic event is the formation of the laryngotracheal grooves on the ventrolateral walls of the primitive foregut, which marks the formation of the tracheal diverticulum. The rostal ( proximal) region of this "lung field" gives rise to the trachea and pharynx, and the caudal (distal) region gives rise to bulges (bronchial buds) that form the right and left bronchi (Fig.  1A) . The bronchial buds follow a branching program that forms the proximal conducting airways and distal alveoli (Fig. 1B) . Simultaneously, formation of the tracheoesophageal groove initiates septation of the foregut, allowing future independent elongation of the tracheal and esophageal tubes (Spooner and Wessells 1970; Williams et al. 2003) .
The epithelial components of the lung and trachea arise from ventral endoderm, which are of distinct embryonic origins from the dorsal esophageal endoderm (Perl et al. 2002b; Brown and James 2009) . Mesenchymal components of the respiratory tract also have distinct origins. Distal lung mesenchyme (mesenchymal, mesothelial, and vascular components of the lung that are distal to the terminal bronchioles) arises from the somatopleure rather than from centripetal growth of tracheal mesenchyme. In contrast, tracheobronchiolar mesenchyme (which gives rise to the connective tissue, cartilage, and smooth muscle components of the trachea and conducting airways and the proximal pulmonary vascular system) arises from splanchnic mesoderm (Brown and James 2009 ).
Transcription Factors and Signaling Molecules
Interact to Pattern the Foregut and Specify Where the Lung and Trachea Will Form
The foregut is composed of an endodermal tube that is surrounded by mesenchyme and mesothelium ( Fig. 1) . Both endoderm and mesoderm contain patterning information, and both tissues are required to specify and initiate lung organogenesis. Explant experiments show that in the absence of mesoderm or mesoderm-specific signals, endoderm does not autonomously form a patterned branched structure. Tissue recombination experiments show that signals from the mesenchyme are essential for the formation of the lung buds and all subsequent stages of lung development. However, unspecified mesoderm from a variety of sources can initiate bud formation from the foregut, whereas distal (terminal bud) bronchial mesenchyme is required to induce later lung-specific epithelial branching (Spooner and Wessells 1970; Hilfer et al. 1985) . Thus, mesenchyme derived from the developing lung contains additional information not found within the less differentiated mesenchyme. Key regulatory molecules, which interact to pattern the foregut, specify the primary lung field, and regulate initial budding, are expressed in both mesoderm and endoderm. These factors include homeobox transcription factors (Hox), retinoic acid (RA), retinoic acid receptors, and mesenchymal-and endodermal-derived growth factors (Fig. 3A) . Hox genes are expressed along the anterior-posterior axis in both endoderm and mesoderm and are proposed to have a primary role in the patterning of the foregut (Lazzaro et al. 1991; Bogue et al. 1996; Sakiyama et al. 2000) . Hoxb5 and Nkx2.1 (thyroid transcription factor 1, Ttf1) are expressed in the primary lung field and are required for subsequent stages of lung development. Hoxb5 is expressed in mesenchyme where it could regulate the expression of secreted factors that pattern the underlying endoderm (Krumlauf et al. 1987 ). However, inactivation of Hoxb5 alone does not affect primary lung bud formation (Rancourt et al. 1995) , making it likely that functional redundancy exists with other Hox genes that have overlapping expression patterns with Hoxb5 (Bogue et al. 1996) .
Nkx2.1 is one of the earliest markers of the lung endoderm (Lazzaro et al. 1991; Minoo et al. 1999) . Nkx2.1 is first expressed in the ventral endoderm of the foregut at E9.5 (Fig. 1A) , and is also expressed in the developing thyroid and brain. Mice lacking Nkx2.1 still form a trachea and lung buds; however, the buds fail to branch, and endodermal differentiation and expression of markers of differentiated lung epithelial cells fail to occur (Minoo et al. 1999) .
Mechanisms that regulate where Nkx2.1 is expressed are poorly understood; however, signaling through the Wnt/ b-catenin pathway in foregut endoderm is required for Nkx2.1 expression and maintenance of respiratory fate (Harris-Johnson et al. 2009 ). More recently, it was shown that the Wnt ligands, Wnt2a (Wnt2) and Wnt2b, are -5) and their position on a circumferential axis (c). Domain branching is followed by orthogonal and planar bifurcations (1b) leading to iterative expansion of the endodermal structure of the lung.
expressed in ventral foregut mesenchyme at the developmental time when the lung is specified (Monkley et al. 1996; Zakin et al. 1998; Goss et al. 2009 ). Inactivation of b-catenin (Ctnnb1) in endoderm, or inactivation of the mesenchymal ligands Wnt2a and Wnt2b, resulted in complete absence of lung development (Fig. 3B ,C) (Goss et al. 2009; Harris-Johnson et al. 2009 ).
In addition to Wnt2a and Wnt2b, fibroblast growth factor 10 (Fgf10) is expressed in mesenchyme adjacent to the sites of lung bud formation. Following formation of the primary lung buds, FGF10 is absolutely required for their initial outgrowth and survival (Bellusci et al. 1997; Min et al. 1998; Sekine et al. 1999; Weaver et al. 2000) . FGF10 signals to FGF receptor 2b (FGFR2b) in foregut endoderm Figure 2 . Stages of lung development. (A) The pseudoglandular stage (mouse E10.5 to 16.5; human E52 to week 17) begins with formation of secondary bronchi and includes formation of conducting airways, a primitive capillary plexus, and differentiation of mesenchyme to form smooth muscle. Histologically, this stage is characterized by glandularlike structures separated by abundant mesenchyme. (B) The canalicular stage (mouse E16.5 to 17.5; human wk 17 to 28) is characterized by thinning of the distal epithelium to form primitive pulmonary acini (terminal sacs), early differentiation of type I and type II pneumocytes (alveolar epithelial cells), and continued angiogenesis and juxtaposition of capillaries with the respiratory epithelium to increase gas exchange surface area. Mesenchyme in the canalicular stage is still relatively abundant. (C) In the saccular stage (mouse E17.5 to postnatal (P) day 5; human wk 28 to 36), the terminal epithelial sacs continue to separate and become enveloped by capillaries. Type II pneumocytes begin to produce surfactant and continue to differentiate into type I pneumocytes. The submesothelial and subepithelial mesenchyme becomes thinner and contains more differentiated cells, including bronchiolar and vascular smooth muscle. (D) During the alveolar stage (mouse P5 to 30; human wk 36 to 40), the terminal epithelial sacs continue to form primary and secondary septa, creating mature alveoli.
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T-box transcription factors (Tbx) 2, 3, 4, 5, and HoxA5 are expressed in foregut and lung mesenchyme, whereas Tbx1 is expressed in foregut endoderm (Chapman et al. 1996; Aubin et al. 1997; Gibson-Brown et al. 1998) . The domain of Tbx4 overlaps with that of Fgf10, and inactivation of Tbx4 results in loss of Fgf10 expression and failure to form lung buds (Sakiyama et al. 2003) . In addition to Tbx4, other mesenchymal factors that may directly regulate Fgf10 expression include Wnt/b-catenin, Hoxb5, and RA signaling Volpe et al. 2007; Chen et al. 2010; Goss et al. 2011) . Bone morphogenetic protein 4 (Bmp4) is expressed in ventral foregut mesenchyme at E9 (19 somite) (Weaver et al. 1999; Li et al. 2008; Danesh et al. 2009) . At this stage, the primary role of Bmp4 is to promote proliferation of anterior foregut mesenchyme (shown by conditional inactivation of Bmp4 with Foxg1-Cre 1 ). In subsequent stages of development, Bmp4 expression is restricted to endoderm (see below). During the embryonic stage of lung development (E9 -E10.5), Bmp4 signaling is required for epithelial tube elongation but not for initial formation of the lung bud or specification of endoderm (expression of Nkx2.1) . However, Bmp4 signaling may restrict formation of lung buds because inactivation of BMP receptors 1a (Bmpr1a, Alk3) and 1b (Bmpr1b, Alk6) in anterior ventral foregut endoderm (Shh-Cre 2 ) resulted in ectopic lung bud formation . Inactivation of only Alk3, in respiratory epithelial cells at a slightly later time using surfactant protein C (Sftpc) regulatory elements (Sftpc-rtTA/TetO-Cre, 3,4 Sftpc-Cre 5 ), resulted in decreased epithelial proliferation and reduced branching (Eblaghie et al. 2006; Sun et al. 2008) . As discussed below, a consequence of loss of BMP signaling in foregut epithelium is tracheal agenesis.
Sonic hedgehog (Shh) is expressed in the ventral foregut and tracheal diverticulum (Fig. 3B,C) (Litingtung et al. 1998) . A primary role for hedgehog signaling in the E9 foregut is to promote mesenchymal proliferation and survival (Litingtung et al. 1998; Motoyama et al. 1998 ). Embryos lacking Shh show delayed formation of the primary lung buds and subsequent failure to branch (Pepicelli et al. 1998) . The phenotype (failure to form primary lung buds) of mice lacking the hedgehog pathway transcription factors, Gli2 and Gli3, is more severe than that of mice lacking Shh (Motoyama et al. 1998 ). This suggests that other hedgehog molecules are involved or that Gli2 and Gli3 have additional hedgehog-independent functions (Motoyama et al. 1998) . Additionally, Gli2 activator function and Gli3 repressor function may compensate for each other. Analysis of independent functions of Gli transcription factor signaling in the embryonic and early pseudoglandular stages indicate that Gli2 increases, and Gli3 decreases, Wnt2b expression (Pepicelli et al. 1998; . Possibly owing to the combined activator and repressor activities of Gli2 and Gli3, embryos lacking Shh have little effect on Wnt2b expression.
RA signaling is also essential for lung bud formation (Desai et al. 2004 (Desai et al. , 2006 . Mice lacking retinaldehyde dehydrogenase 2 (Raldh2), but supplemented with RA from E7.5 to E8.5 to allow embryo development to progress, fail to develop lungs and do not express Fgf10 in foregut mesenchyme . The mechanisms by which RA signaling regulates Fgf10 expression are complex and indirect and appear to be mediated through Wnt and Tgfb signaling pathways (Fig. 3C) . The Wnt antagonist, Dkk1, is expressed throughout the foregut, but is excluded from the primary lung fields. In the foregut lung fields, RA signaling functions to suppress Dkk1 expression in mesoderm and endoderm. This allows increased Wnt signaling and up-regulation of Fgf10 (Chen et al. 2007 (Chen et al. , 2010 . RA signaling also suppresses Tgfb signaling in lung field mesenchyme (Chen et al. 2010) . In mice that lack Raldh2, partial rescue can be achieved by activation of Wnt signaling (Chen et al. 2007 ); however, complete rescue requires simultaneous suppression of Tgfb signaling and activation of Wnt signaling (Chen et al. 2010 ). These studies suggest that both activation of Wnt signaling and suppression of Tgfb signaling are required for Fgf10 expression in foregut mesenchyme and that RA signaling functions to coordinate the activity of these pathways (Chen et al. 2010 ).
The Trachea and Esophagus Form by Septation of the Foregut Tube
Soon after formation of the primary lung bud, the foregut begins to separate dorsoventrally into two parallel tubes, the esophagus and trachea (Figs. 1A and 3D). SHH and BMP signaling are required for growth of the trachea and separation of the tracheal and esophageal tubes. The transcription factor, Nkx2.1, is also required for septation of the trachea and esophagus, and mice lacking Nkx2.1 form a common tube between the pharynx and stomach (Minoo et al. 1999) . The BMP antagonist, Noggin, is expressed in dorsal foregut mesenchyme where it opposes the activity of BMP4 (Fig. 3D ). Bmp4 is expressed in ventral foregut mesenchyme (Weaver et al. 1999; Li et al. 2008 ) and inactivation of Bmp4 (Foxg1-Cre) resulted in agenesis of the tracheal tube . However, in these conditional knockout embryos, at the 20 -22 somite stage (E9.25), anterior endoderm still expressed Nkx2.1, showing that BMP4 signaling is not required for respiratory 1 FoxG1-Cre is expressed in the foregut endoderm as early as E8.5 and in endoderm and mesenchyme by E9.5 ).
2 Shh-Cre contains a GFP-Cre fusion gene inserted into the Shh locus (Harfe et al. 2004 ). In the lung, the Shh-Cre allele is expressed exclusively in endoderm.
3
The Sftpc-rtTA transgene targets expression of the reverse tetracycline transactivator protein (rtTA) to most lung endoderm by E10.5 (Perl et al. 2002a ). In the presence of doxycycline, rtTA can activate tetracycline response elements (TetO) (Valencik and McDonald 2001) .
4
The TetO-Cre transgene allele allows tetracycline-regulated expression of Cre recombinase (Perl 2002b ).
5
The Sftpc-Cre transgene drives Cre expression in lung endoderm (Okubo et al. 2005 ).
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Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008318 epithelial specification, but is required for outgrowth . Inactivation of Bmpr1a and Bmpr1b in endoderm (Shh-Cre) resulted in a similar tracheal agenesis phenotype . In embryos lacking endodermal BMP receptors (BMPRs), expression of Nkx2.1 was significantly decreased in the anterior foregut endoderm by E10.5, consistent with a requirement of BMP signaling to maintain respiratory lineage differentiation. At this stage, the single endodermal tube lacked tracheal identity and expressed esophageal markers . Mice lacking Noggin (Nog 2/2 ) have increased BMP signaling and show a phenotype opposite to that seen in the BMP pathway loss-of-function mutants. Seventy percent of mice lacking Noggin develop esophageal atresia or a tracheal-esophageal fistula (Que et al. 2006) . Consistent with BMP signaling promoting the respiratory lineage, Nog 2/2 mice show decreased growth of the esophagus, expanded expression of Nkx2.1, and formation of cartilage in the posterior common gut tube. Thus, BMP signaling functions to promote respiratory cell fate in foregut endoderm.
Shh is expressed in the ventral foregut and at the highest levels in the tracheal diverticulum ( Fig. 3B-D) (Litingtung et al. 1998) . Shh 2/2 embryos fail to form a distinct esophagus and trachea owing to failure to form the tracheoesophageal septum. In Shh 2/2 embryos, the common tube that extends to the stomach has predominantly tracheal morphology (Litingtung et al. 1998; Pepicelli et al. 1998; Miller et al. 2004 ). In the Shh 2/2 mutants, mesenchymal, but not endodermal, Bmp4 expression is decreased. At later stages, Shh functions downstream from Fgf10 and Fgfr2b to regulate patterning of Sox9 expression and formation of the cartilaginous tracheal rings ( Fig. 3D) (Miller et al. 2004; Park et al. 2010; Sala et al. 2011) . Shh thus functions at multiple levels to promote respiratory fate in the foregut and regulate the separation between the esophagus and trachea.
FORMATION OF THE DISTAL RESPIRATORY TREE

Stereotyped Branching Patterns in the Primary Lung Lobes
The lung is subdivided into primary lobes or domains that are formed from branches off the primary bronchi. The branching pattern that forms these major subdivisions of the lung shows left-right asymmetry and is species specific. In humans, the left lung is composed of an upper (superior) and lower (inferior) lobe, whereas the right lung has a superior, middle, and inferior lobe (Gray 2000) . In the mouse, the left lung is composed of only one lobe and the right lung is divided into four lobes: the caudal, cranial, middle, and accessory lobes. The patterning of these major divisions of the lung is regulated by a type of branching called domain branching (Metzger et al. 2008b ).
The mechanisms that specify where domain branches will occur are not known; however, it is likely that this type of branching uses mechanisms that are distinct from those that control subsequent, more repetitive types of branching (Metzger et al. 2008b; Warburton 2008) . Studies of the architecture of airway branch points revealed that there are two modes of domain branching coupled with a "periodicity generator" that specifies when a new branch will form and the spacing between branches (Metzger et al. 2008b ). The first mode of domain branching regulates the location of buds along the proximal -distal axis, and the second mode regulates the position of buds on a circumferential axis (Fig. 1C) . These mechanisms are discussed in more detail in Ochoa-Espinosa and Affolter (2012).
The left-right asymmetry of the lung that results from domain branching is ultimately controlled by earlier developmental mechanisms that regulate asymmetry of the embryonic axes (genes include nodal, Lefty1 and 2, Pitx2, Hfh4 (Foxj1), and Gli2). Other genes act later in development to implement the asymmetric developmental program (Cardoso and Lu 2006; Warburton et al. 2010) . Defects in some genes result in randomization of left and right sides of the body plan while maintaining asymmetry, whereas defects in other genes lead to loss of asymmetry (isomerization). For example, the lungs of Shh 2/2 embryos fail to branch beyond formation of the right and left primary lung buds, resulting in symmetric single left and right lobes (Pepicelli et al. 1998 ). Development of the lungs of Gli2 2/2 embryos progresses farther than that of Shh 2/2 embryos, but still only form a single right lobe (Motoyama et al. 1998 ). Interestingly, loss of hedgehog interacting protein (Hip1), a negative regulator of hedgehog signaling, also results in a lung with only single left and right lobes instead of the normal four-lobed right lung (Chuang et al. 2003) . Hip1 is expressed in mesenchyme, distal to where a branch will form. The underlying mechanism appears to be increased hedgehog signaling and suppression of Fgf10 expression in distal tip mesenchyme (Fig. 3B,C) . In contrast to embryos with defects in the hedgehog signaling pathway, embryos lacking Pitx2 have four-lobed lungs on both the right and left side (Kitamura et al. 1999) .
Even though the specific molecules that pattern branching have not been identified, it is clear that the formation of the initial domain branches and all subsequent branches are dependent on the expression of Fgf10 in mesenchyme distal to the branch point. Therefore, understanding the mechanisms that regulate where Fgf10 is expressed is thus critical for understanding how the bronchial tree is patterned (Warburton 2008) . The primary sites of Fgf10 expression are hypothesized to be partially under the control of Hox family transcription factors, which are expressed in specific patterns throughout foregut and lung mesenchyme. In support of this idea, Hoxb3-b5 are expressed in foregut mesenchyme at E9.5 in the region where the lung buds will form (Fig. 3A) , and Hoxb2 -b5 are expressed in mesenchyme surrounding budding epithelium (Bogue et al. 1996) . In an explant culture system, knockdown of Hoxb5 showed that it functions to localize the expression of Fgf10 in mesenchyme, and that it may also control Fgf10 signaling through regulation of extracellular matrix molecules (Volpe et al. 2007 ). In addition to Hox genes, the transcription factors Tbx4 and Tbx5 are required for Fgf10 expression in lung field mesenchyme (Cebra- Thomas et al. 2003; Sakiyama et al. 2003) . RA, which is required for Fgf10 expression and formation of the primary lung buds, must be down-regulated in distal tip mesenchyme for Fgf10-dependent secondary branching to occur (Malpel et al. 2000) .
Molecular Mechanisms Regulating Branching Morphogenesis
The formation of the terminal branching pattern of conducting airways uses the two domain-branching mechanisms ( proximal -distal and circumferential), and also implements two types of tubular bifurcations ( planar and orthogonal) (Metzger et al. 2008b ). The precise mechanisms that specify which modes of branching will occur are not known. However, it is clear that these patterning mechanisms must regulate intrinsic and extrinsic signals that specify the location of branch points through the regulation of epithelial proliferation, cell shape, cell division planes, and movement. These cellular events are controlled by the dynamic interaction of signaling molecules, inhibitors, receptors, and the extracellular matrix within a "signaling center" comprised of distal airway epithelium, surrounding mesenchyme, and the overlying mesothelium ( Fig. 3A ) (Cardoso 2000; Warburton et al. 2005; Cardoso and Lu 2006; Morrisey and Hogan 2010) . One "hard-wired" genetic program that could guide the stereotyped branching pattern of the lung may involve specification of regional identity of lung mesenchyme by Hox transcription factors (Bogue et al. 1996) . During early pseudoglandular stage development (E10.5-E14.5), there are two patterns of Hoxb gene expression. Hoxb3 and Hoxb4 are expressed in proximal and distal lung mesenchyme, whereas Hoxb2 and Hoxb5 messenger RNA (mRNA) are only expressed in distal lung mesenchyme (Bogue et al. 1996) . Sakiyama showed that expression domains of Hoxb6 -Hoxb9 correspond to the morphological subdivisions of the air sacs along the proximodistal axis and that dorsal and ventral pulmonary mesenchyme, demarcated by Hoxb6 expression, have different inductive capacities toward the tracheal epithelium (Sakiyama et al. 2000) . Future genetic experiments in which multiple Hox genes are inactivated will be required to determine the extent to which they influence branching patterns of the respiratory tree.
Progenitor Cells Positioned along the
Proximodistal Axis Give Rise to Differentiated Cells in the Alveoli and Conducting Airways
Lung epithelial progenitor cells are thought to reside in the distal tip region of the developing respiratory bud (Rawlins et al. 2009 ). As the lung matures and daughter cells assume more proximal positions along the respiratory tree, they differentiate into multiple cell types that populate the distal (alveolar) and proximal (conducting) airways Rock and Hogan 2011 and function to mediate efficient gas exchange with juxtaposed capillary endothelial cells (Stone et al. 1992 ). The conducting airways are lined by Clara, ciliated, neuroendocrine and basal cells. More proximal conducting airways also contain mucus-producing goblet cells. Clara cells express secretoglobulins such as Clara cell secretory protein (CCSP or CC10); neuroendocrine cells produce neuropeptides such as calcitonin. During development, a Clara-like cell can give rise to both ciliated and neuroendocrine cells, and the ratio of these two cell types is governed by Notch signaling (Tsao et al. 2009 ). In mature lungs, cells with progenitorlike properties include type II alveolar epithelial cells, cells located in the bronchoalveolar duct junction (BADJ) and the basal cells along conducting airways (Giangreco et al. 2002 (Giangreco et al. , 2009 Kim et al. 2005) .
Autocrine and Paracrine Signals Interact to Regulate Epithelial Cell Proliferation
Lung epithelial cells express receptors for FGF10 (Fgfr2b), BMP4 (Bmpr1a/Alk3 and Bmpr1b), the canonical Wnt ligand, Wnt7b (Fzd10), and the noncanonical Wnt ligands, Wnt5a (Fzd2) Eblaghie et al. 2006; Zhang et al. 2008 ) and Wnt11 (Lako et al. 1998) . Of these, the BMP signaling pathway has been shown to regulate epithelial proliferation during pseudoglandular stage lung development. During this stage, Bmp4 expression is restricted to the epithelium at the tip of the lung buds (Weaver et al. 1999; Jang et al. 2010 (Weaver et al. 1999; Eblaghie et al. 2006) . Thus, BMP4 functions as an autocrine growth factor for lung epithelium. Extrinsic regulation of BMP4 signaling appears to be mediated by the BMP antagonists, Noggin (Nog) and Gremlin (Grem1), which are expressed in adjacent mesenchyme (Weaver et al. 1999 (Weaver et al. , 2003 Shi et al. 2001) . Knockdown of Grem1 in explant cultures with antisense oligonucleotides resulted in increased epithelial proliferation and increased differentiation (expression of Sftpc) (Shi et al. 2001) . Gremlin 1 knockout mice (Grem1 2/2 ) die at birth with defects in alveolar septation, as well as a multilayered epithelium (Michos et al. 2004) . Noggin knockout mice (Nog LacZ/LacZ ) have abnormal truncations of lung lobes but no other reported lung phenotypes (Brunet et al. 1998; McMahon et al. 1998; Weaver et al. 2003) . Functional redundancy between Grem1 and Noggin has not been investigated.
Wnt signaling also regulates epithelial proliferation, although indirectly. Mouse embryos that are null for Wnt7b show decreased epithelial and mesenchymal proliferation primarily in the region of the distal epithelial tip without any increase in cell death (Rajagopal et al. 2008) . Wnt7b likely signals to epithelial Fzd10 and mesenchymal Fzd1 . The pathway through which canonical Wnt7b signaling regulates epithelial proliferation appears to be mediated through mesenchyme. Inactivation of epithelial b-catenin did not affect epithelial proliferation but rather impaired distal differentiation (Mucenski et al. 2003) . Furthermore, Bmp4 expression was normal in the epithelium of lungs lacking Wnt7b or epithelial b-catenin (Mucenski et al. 2003; Shu et al. 2005 ). However, inactivation of mesenchymal b-catenin resulted in decreased epithelial proliferation, probably through derepression of mesenchymal noggin and resulting inhibition of Bmp4 signaling ( Fig. 4A) (Yin et al. 2011) .
Wnt5a is expressed in lung epithelium and adjacent mesenchyme and at highest levels around the distal tip (Li et al. 2002) . Wnt5a signals through the noncanonical receptor Fzd2 (Sato et al. 2010 ). Inactivation of Fzd2 or Gata6 (which regulates Fzd2) resulted in increased epithelial proliferation, increased Bmp4 expression, and increased canonical Wnt signaling (Fig. 4B) (Bellusci 2008; Zhang et al. 2008 ). However, Wnt5a 2/2 lungs showed no change in epithelial proliferation or apoptosis during pseudoglandular stages (E13.5) ), but increased proliferation during saccular stages (E18.5) (Li et al. 2002) .
FGF10 signaling enhances epithelial proliferation (Bellusci et al. 1997; Weaver et al. 2000; Ramasamy et al. 2007 ); however, this activity is independent of PI3K and p-Erk activation (Metzger et al. 2007; Tang et al. 2011) . Therefore, the effects of FGF10 on epithelial proliferation may be mediated through other FGFR signaling pathways (such as gPLC) or indirectly through FGF10/FGFR2b-induced increases in the expression of Bmp4 (Lebeche et al. 1999; Weaver et al. 2000; Hyatt et al. 2004 ), a known regulator of epithelial proliferation.
Secreted Morphogens Have a Key Role in Regulating Epithelial Branching and Differentiation
FGF10 signaling to FGFR2b is required for formation of epithelial buds throughout embryonic and pseudoglandular stages of lung development (Figs. 3C and 4B) (Min et al. 1998; Sekine et al. 1999; Ramasamy et al. 2007; Abler et al. 2009 ). Studies on the mechanisms of bud formation indicate that initial bud outgrowth occurs independent of proliferation and then, after bud initiation, proliferation increases in distal epithelium (Nogawa et al. 1998) . Consistent with this, FGF10 has been shown to induce chemotaxis toward the source of FGF10, as well as having some mitogenic activity on lung epithelial explants (Bellusci et al. 1997; Weaver et al. 2000; Hyatt et al. 2004; Li et al. 2005 ). FGF10 also promotes distal cell fate, and inactivation of FGF10/FGFR2b signaling leads to expansion of proximal cells that express Sox2 and loss of distal epithelial cells that express Sox9 (Abler et al. 2009 ). It is not known whether this effect on epithelial differentiation is direct or mediated through another pathway. Consistent with the latter model, FGF10 signaling is required for epithelial canonical Wnt signaling (Ramasamy et al. 2007) , which functions to regulate distal epithelial differentiation (Mucenski et al. 2003) . FGF9 signaling also contributes to epithelial branching (Fig. 4C) . Although epithelial-expressed FGF9 signals to lung mesenchyme (see below), it also can signal directly to lung epithelium where it affects epithelial morphology and promotes branching (del Moral et al. 2006a; White et al. 2006; Yin et al. 2008 Yin et al. , 2011 . Effects of FGF9 on branching could be mediated through induction of Dkk1 expression and inhibition of Wnt signaling in distal lung epithelium (del Moral et al. 2006a ). Canonical Wnt signaling within lung endoderm is required for distal epithelial differentiation and branching (Mucenski et al. 2003; Shu et al. 2005 ) and inhibition of Wnt signaling by overexpression of Dkk1-blocked distal epithelial differentiation and fibronectin expression . Interestingly, fibronectin is essential for formation and stabilization of the branch cleft (Sakai et al. 2003) .
FGF signaling is negatively regulated by Sprouty (Spry) genes and Spry1, 2, and 4 are expressed in distal tip epithelium, adjacent to where Fgf10 is expressed in mesenchyme (Fig. 4B) (Zhang et al. 2001; Hashimoto et al. 2002) .
Development of the Lung
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Inactivation of Spry1 and/or Spry2 results in increased branching, differentiation toward distal airway cell types, and epithelial dilation (Tefft et al. 1999; Taniguchi et al. 2007; Tang et al. 2011) . Inactivation of Spry2 and Spry4 resulted in epithelial dilation and increased mesenchyme (Taniguchi et al. 2007 ). In contrast, overexpression of Spry2 suppressed branching and occasionally led to the agenesis of entire lung lobes (Mailleux et al. 2001) .
The expression pattern of Fgf10 is dynamic and spatially restricted to distal mesenchyme by SHH signaling (Bellusci et al. 1997; Pepicelli et al. 1998; Lebeche et al. 1999) . SHH also promotes Wnt2a expression in distal mesenchyme, and Wnt2a promotes mesenchymal differentiation and Fgf10 expression (Goss et al. 2011) . FGF10/ FGFR2b signaling is, in turn, required to maintain Shh expression ( Fig. 4B ) (Abler et al. 2009 ). In distal mesenchyme, RA negatively regulates Fgf10 expression and RA must be down-regulated distally for normal branching (Fig. 3C ) (Malpel et al. 2000) . Noncanonical Wnt signaling also regulates epithelial branching. Embryos that lack Wnt5a (Wnt5a 2/2 ) have increased branching and increased expression of Fgf10, Bmp4, and Shh, whereas embryos that overexpress Wnt5a have reduced epithelial branching (Fig. 4B) (Li et al. 2002 .
Regulation of Cell Shape and Polarity Is Necessary for Epithelial Morphogenesis
Initiation of bud formation requires changes in cell shape, polarity, and cell-cell interactions. Several factors have been identified that regulate cell shape, polarity, and adhesion. FGF10 signaling to distal epithelium activates PI3K/ Akt to induce expression of the Ets transcription factor Elf5 (Metzger et al. 2007 ). Although overexpression of Elf5 disrupts branching and suppresses distal epithelial differentiation (Metzger et al. 2008a) , it is not known whether Elf5 is necessary for epithelial morphogenesis. The mitogen-activated protein (MAP) kinase, p38a, is localized specifically in the distal endoderm and inhibition of p38a impairs epithelial budding. p38a can be activated in response to FGF10 and it functions to inhibit E-cadherin expression. Down-regulation of E-cadherin is necessary for budding, and budding can be in-hibited by overexpression of Ecadherin (Liu et al. 2008) . Although inhibition of Erks (expressed throughout lung epithelium) also prevented FGF10-induced budding, the mechanism is independent of regulation of E-cadherin, and likely due to the effects of Erk signaling on cell shape and spindle polarity (Liu et al. 2008; Tang et al. 2011) . The protein tyrosine phosphatase and transcriptional coactivator, eyes absent (Eya1) and the homeobox gene, Six1, are also expressed in distal epithelium (El-Hashash et al. 2011a,b) . Embryos lacking Eya1 or Six1 have severely hypoplastic lungs. However, during the mid to late pseudoglandular stage, they show increased mesenchymal proliferation and decreased epithelial proliferation. In the epithelium, one function of Eya1 is to regulate cell polarity and the plane of cell division during branching (El-Hashash et al. 2011c) . Several additional factors have been identified that function to fine-tune the branching process. These include netrin 1 and netrin 4, Celsr1, and Wnt5a. The guidance molecules, netrin 1 and netrin 4, are expressed in nonbranching ( proximal) endoderm and are excluded from the distal tip. The netrin receptor, DCC, is expressed in the basal-lateral membrane of proximal endoderm and on the apical surface of distal tip epithelium. The netrin coreceptor, Unc5b, is also expressed in distal epithelium. Netrin signaling inhibits FGF10-induced pErk, effectively preventing ectopic budding and fine-tuning the shape of the bud (Liu et al. 2004 ). Loss-of-function mutations in the planar cell polarity genes, Celsr1 and Vangl2, result in reduced lung epithelial budding and abnormal epithelial cell morphology (Yates et al. 2010 ). Celsr1 colocalizes with laminin in regions where bud growth is constrained and thus may be important for bud bifarcation or stabilization of the cleft between branches (Yates et al. 2010) . Lung epithelium, in Celsr1 and Vangl2 mutants, has an impaired response to FGF10, resulting in lung hypoplasia.
Molecular Mechanisms Regulating Mesenchymal Growth and Differentiation
The mesenchymal compartment of the developing lung gives rise to the lung vasculature (endothelial cells, pericytes, and vascular smooth muscle), bronchial smooth muscle, myofibroblasts, and interstitial fibroblasts. Lung mesenchyme is also essential for regulating the patterning and extent of epithelial branching and is a key determinant in regulating the overall size and shape of the lung. Proximo-distal patterning of the lung may be, in part, intrinsic to lung mesenchyme because mesenchymal protrusions occur even in the absence of FGF10/FGFR2b signaling and epithelial branching (Abler et al. 2009 ). Lung mesenchyme is not homogeneous, and histological criteria and molecular markers subdivide it into submesothelial (SMM) and subepithelial (SEM) domains (White et al. 2006 ). Submesothelial mesenchyme is marked by expression of Wnt2a, and subepithelial mesenchyme expresses Noggin (Fig. 5A,B ) (Levay-Young and Navre 1992; Bellusci et al. 1996; Weaver et al. 2003; Yin et al. 2008) . Progenitor cells for bronchial smooth muscle and interstitial fibroblasts are located in the distal tip submesothelial mesenchyme , whereas vascular endothelial cells are first observed between submesothelial and subepithelial zones (Fig. 5C,D) (Partanen et al. 1996; Hall et al. 2000; White et al. 2006 White et al. , 2007 . Neuronal components of the lung are derived from migrating neural crest cells that begin to populate foregut mesenchyme before formation of the lung bud and continue to enter the lung during early pseudoglandular development (Tollet et al. 2001 ).
FGF and Wnt Signals Regulate Lung Mesenchyme Development
Fgf9 is a critical regulator of lung mesenchyme. Fgf9 is expressed in the mesothelium and epithelium (Fig. 4 ) (Colvin et al. 1999; del Moral et al. 2006a ). In the absence of FGF9 (Fgf9 2/2 ), lungs are severely hypoplastic, resulting in perinatal death (Colvin et al. 2001; White et al. 2006 ).
Fgf9
2/2 embryos show decreased mesenchymal proliferation and decreased epithelial branching.
FGF9 primarily signals to mesenchymal FGF receptors (FGFRs) 1 and 2, but also can activate epithelial FGFR signaling (del Moral et al. 2006a; White et al. 2006 White et al. , 2007 Yin et al. 2008) . During the early (E12.5) pseudoglandular stage, mesenchymal FGF signaling and Wnt/b-catenin signaling function to positively reinforce each other (Fig.  4C) (Yin et al. 2008 (Yin et al. , 2011 . Mesenchymal FGF signaling is required for expression of Wnt2a, and mesenchymal Wnt/ b-catenin signaling is required to sustain expression of FGFRs 1 and 2 (De Langhe et al. 2008; Yin et al. 2008 Yin et al. , 2009 . Consistent with this feed-forward signaling loop, inactivation of mesenchymal b-catenin also results in decreased mesenchymal proliferation and decreased cyclinD1 expression (Yin et al. 2008) .
Inactivation of a conditional allele of Fgf9 (Lin et al. 2006) in mesothelium (Dermo1-Cre 6 ) (Figs. 4C and 5E) showed that mesothelial-derived FGF9 is primarily responsible for regulating mesenchymal proliferation and has little influence on epithelial branching. In contrast, inactivation of Fgf9 in epithelium (Shh-Cre) showed that epithelial-derived Fgf9 influences epithelial branching and epithelial proliferation but has little effect on mesenchymal proliferation (Figs. 4C and 5F) (Yin et al. 2011) . In Fgf9 2/2 lung or in lungs in which mesenchymal b-catenin has been conditionally inactivated (Dermo1-Cre), lung mesenchyme cannot be rescued by addition of exogenous FGF9 (Yin et al. 2008 (Yin et al. , 2011 . This loss of responsiveness of mesenchyme is attributable to degeneration of feed-forward FGFWnt/b-catenin signaling and loss of mesenchymal FGFR expression. Fgf9 2/2 mesenchyme can, however, be rescued if FGF9 is added along with agents that stabilize b-catenin (LiCl, BIO) (Yin et al. 2011 ). In addition to mesothelial and epithelial Fgf9 and mesenchymal Wnt2a, Wnt7b (expressed in developing epithelium) is also required for lung development where it activates mesenchymal and epithelial Wnt/b-catenin signaling (Rajagopal et al. 2008; Yin et al. 2011) . Examination of mesenchymal growth in explant cultures shows a small response to activation of Wnt/bcatenin signaling and a large response to FGF9, indicating that FGF9 signaling is the dominant pathway regulating mesenchymal proliferation and suggesting that Wnt/bcatenin signaling primarily functions as a permissive factor for FGF9/FGFR1c/2c signaling (Yin et al. 2011) .
Also observed in lungs lacking mesenchymal FGF or Wnt/b-catenin signaling was decreased epithelial The Dermo1-Cre knockin allele drives Cre recombinase expression in mesenchyme (Yu et al. 2003) .
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proliferation, which occurred later in development than the decreased mesenchymal proliferation. This suggests that loss of mesenchymal FGF or b-catenin signaling has a primary effect on mesenchymal proliferation and a secondary (delayed) effect on epithelial proliferation. A potential mechanism by which mesenchymal FGF-Wnt/b-catenin signaling could regulate epithelial proliferation is through modulation of BMP4 signaling. Two endogenous inhibitors of BMP4 signaling, Grem1 and Noggin, are expressed in pseudoglandular stage lung mesenchyme (Weaver et al. 1999 (Weaver et al. , 2003 Shi et al. 2001) . In lung explant cultures, FGF9 beads suppress Noggin expression (Weaver et al. 2003) , and in embryonic lung that lacks mesenchymal FGF or Wnt/bcatenin signaling, Noggin expression is up-regulated (Yi et al. 2009 (Yi et al. , 2011 . Treatment of lung mesenchymal explants with SHH also leads to increased Noggin (Weaver et al. 2003) .
Smooth Muscle Differentiation Is Regulated by Factors Intrinsic and Extrinsic to Lung Mesenchyme
Wnt signaling regulates the progenitor cells that give rise to bronchial (Wnt2a, Wnt7b) and vascular (Wnt7b) smooth muscle (Shu et al. 2002; Wang et al. 2005; Cohen et al. 2009; Goss et al. 2011) . Consistent with the role of Wnt ligands in smooth muscle development, inactivation of mesenchymal Wnt/b-catenin signaling impairs the development of progenitor cells that give rise to bronchial and vascular smooth muscle (De Langhe et al. 2008; Cohen et al. 2009 ). Expansion of bronchial smooth muscle progenitors is likely mediated by submesothelial Wnt2a (Goss et al. 2011) , whereas Wnt7b signaling through Fzd1 preferentially regulates differentiation of vascular smooth muscle (Shu et al. 2002; Wang et al. 2005) . Wnt signaling may promote smooth muscle differentiation by up-regulating the expression of Pdgfrb Goss et al. 2011) , which is required for normal smooth muscle development. In addition, FGF9 signaling inhibits and BMP4 signaling promotes bronchial smooth muscle differentiation (Weaver et al. 2003; Mailleux et al. 2005; White et al. 2006; Yi et al. 2009) , and SHH signaling is important for the formation of bronchial and tracheal (but not vascular) smooth muscle, and possibly for the survival of vascular smooth muscle (Pepicelli et al. 1998; Miller et al. 2004; van Tuyl et al. 2007 ).
Coordination of Vascular and Epithelial Development
Lung vascular development occurs concurrently with epithelial branching morphogenesis (Gebb and Shannon 2000; Schachtner et al. 2000; Parera et al. 2005) . During early pseudoglandular development, the primitive capillary plexus expands by angiogenesis (sprouting from preexisting vessels) and is maintained at a constant distance from the epithelial ducts (deMello et al. 1997; Hall et al. 2000) . VegfA is essential for vascular development, and vascular development is required for normal epithelial branching (Lazarus et al. 2011) . In explant culture, VegfA is sufficient to stimulate neoangiogenesis (Healy et al. 2000) , to increase mesenchymal Flk1 (Vegfr2)-positive cells and, by poorly understood mechanisms, to promote epithelial branching morphogenesis (Del Moral et al. 2006b; Lazarus et al. 2011) . Inhibition of VegfA (overexpression of secreted Vegfr1) reduces vascular development and impairs epithelial development, resulting in malrotation of dorsoventral branches and inhibition of orthogonal bifurcations (Gerber et al. 1999; Ng et al. 2001; Zhao et al. 2005; Lazarus et al. 2011 ). In the absence of blood vessels, Fgf10 expression domains were expanded and Shh and Sprouty2 levels were increased, suggesting that the vasculature actually plays a key role in coordinating epithelial morphogenesis. During early pseudoglandular stage development, VegfA is expressed throughout lung mesenchyme, and endothelial cells are localized between submesothelial and subepithelial domains (Fig. 5C) (White et al. 2007 ). Slightly later, the capillary plexus is drawn toward the epithelial tubes coincident with increased expression of epithelial VegfA (Healy et al. 2000; White et al. 2007) . During the saccular stage (E18.5), VegfA expression becomes restricted to a subpopulation of cells that line the saccular walls, and VegfA protein is localized in distal lung epithelial cells where it serves as a chemotactic signal for the vasculature (Healy et al. 2000; White et al. 2007; Ahlbrecht et al. 2008) .
In addition to VegfA, FGF9, SHH, and Wnt/b-catenin signaling regulate vasculogenesis. FGF9 suppresses vasculogenesis but does not directly affect endothelial cell development (del Moral et al. 2006a) . Rather, FGF9 indirectly regulates capillary plexus density through regulation of mesenchymal (but not epithelial) VegfA expression (White et al. 2007) . SHH is required for normal vasculogenesis and endothelial cell survival and functions independent of FGF9 (Miller et al. 2004; van Tuyl et al. 2007; White et al. 2007) . Wnt7b is required for formation of the smooth muscle component of the major pulmonary vessels (Shu et al. 2002) .
MicroRNAs Regulate Epithelial and
Mesenchymal Gene Expression to Fine-Tune Lung Development
MicroRNAs regulate mRNA stability and translation and have important roles in fine-tuning development. Dicer1, and other enzymes required to process microRNAs, are
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Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008318 expressed in pseudoglandular stage distal mesenchyme and epithelium ). Inactivation of a conditional allele of Dicer1 throughout lung epithelium (Shh-Cre) resulted in the formation of large epithelial pouches, reduced epithelial branching, and mesenchymal thickening (Harris et al. 2006) , phenotypes that were first evident at E12.5. Later in development (E13.5), increased epithelial cell death was observed. Examination of the expression patterns of genes that could directly affect epithelial morphogenesis identified increased expression of mesenchymal Fgf10 (Harris et al. 2006 ). However, because Dicer1 was specifically inactivated in epithelium, it is likely that epithelial microRNAs regulate an epithelial gene that encodes a factor that signals to mesenchyme that regulates Fgf10 expression. The two most likely candidate genes are Fgf9 and Shh. Many microRNAs are differentially expressed during lung development (Williams et al. 2007; Bhaskaran et al. 2009; Carraro et al. 2009; Dong et al. 2010) . Several of these microRNAs have been identified as important for lung development and the pathogenesis of lung cancer and other lung diseases. miR-127 is expressed at highest levels in saccular stage lung development. Overexpression of miR-127 in explant cultures of pseudoglandular stage lung caused decreased branching and enlarged terminal buds (Bhaskaran et al. 2009 ). miR-17 and its paralogs, miR20a and miR-106b, are expressed in epithelium and mesenchyme during pseudoglandular stage development. Inhibition of these three miRNAs in epithelial explants impaired FGF10-induced budding. Mapk14 and Stat3 are direct targets of miR-17 and are thought to regulate expression of E-cadherin (Carraro et al. 2009 ). Transgenic overexpression of the miR-17-92 cluster (miR-17-5p, -17-3p, -18a, -19a, -19b, -20a, and -92a) under the control of Sftpc regulatory elements enhances the proliferation and selfrenewal of embryonic lung epithelial progenitor cells and delays their differentiation (Lu et al. , 2008 . Mouse embryos lacking the miR-17-92 cluster showed severely hypoplastic lungs at E18.5, but without specific defects in branching morphogenesis (Ventura et al. 2008) . The miR302/367 cluster is a direct target of Gata6 in early pseudoglandular stage airway epithelium. After E12.5, miR302/ 367 expression declines. Inactivation of miR302/367 activity results in decreased epithelial proliferation and enhanced differentiation . miR302/367 functions to repress expression of the tumor suppressor, Rbl2, and the cell-cycle regulator, Cdkn1a, as well as the polarity factors, Tiam1 and Lis1 ). miR17-92 also targets Rbl2 . These microRNAs thus function to coordinate endodermal proliferation, differentiation, and apical-basal polarity (Lu et al. 2008; Tian et al. 2011 ).
REGULATION OF LUNG SIZE AND SHAPE
Mechanisms that regulate the size and the shape of the lung are a particularly intriguing problem. As discussed above, there are multiple genetically encoded factors that determine the overall lobulation pattern of the lung and that even specify the stereotypic location and orientation of the first several generations of branches. However, the structure of the lung is sufficiently complex, such that additional extrinsic factors must also modulate its development. For example, throughout the later stages of embryonic development and beyond, the shape of the lung conforms precisely to that of the thoracic cavity, whereas lung explants grown in vitro take on a more rounded shape. Thus, constraints imposed by the thoracic cavity must act to shape the lung.
Extrinsic Factors that Regulate Lung Size
Changes in intrathoracic pressure have been considered as a mechanism that could regulate growth of the lung and even sculpt the lung to the contour of the thoracic cavity. During development, fetal respiratory movements and intratracheal fluid production produce pressure changes within and around the developing lung. Fetal respiratory movements have been detected as early as E14.5 in the mouse (Abadie et al. 2000) and at 10 wk gestation in human (de Vries et al. 1986 ).
The importance of fetal mechanical forces on lung development has been shown by tracheal occlusion, which increases intratracheal pressure, or in mice congenitally lacking muscle activity, which prevents fetal breathing movements. Increased intratracheal pressure resulted in increased branching, proliferation, and branch elongation. These effects are dependent on intact FGF10/FGFR2b signaling (Unbekandt et al. 2008) . Mice lacking the myogenic factors MyoD and/or Myf5 had hypoplastic lungs, decreased epithelial proliferation, increased apoptosis, and failure to fully differentiate type I and type II pneumocytes (Liu and Post 2000; Inanlou and Kablar, 2005a,b; BagumaNibasheka et al. 2007) .
Mechanical stretch stimulates lung epithelial cell proliferation and promotes cell maturation (Liu and Post 2000) . One mechanism is through the regulation of Rho activity. Rho, a GTPase that promotes the phosphorylation of myosin light chain kinase (MLCK), activates the Rhoassociated kinase (ROCK), inhibits MLC phosphatase, and stimulates cytoskeletal contractility (Olson 2004; Moore et al. 2005) . Inhibition of the Rho/ROCK signaling pathway in lung explant cultures decreased branching without affecting cell proliferation (Moore et al. 2005) .
Congenital space occupying lesions in the chest, such as congenital diaphragmatic hernia and cystic adenomatoid malformation of the lung, can severely limit lung growth (Kinane 2007; Robinson and Fitzgerald 2007) . Limits imposed by the chest wall and diaphragm also limit lung size. However, in rodents and young children, partial pneumonectomy results in compensatory growth of the contralateral lung to restore respiratory capacity (McBride et al. 1980) . Therefore, physical and humeral factors can overcome intrinsic genetic programs. Additionally, environmental factors, imposed by altitude or pollution, can also affect lung development and function (Dashdendev et al. 2011) .
PERSPECTIVES
The origins of chronic lung disease often begin during embryonic development or early in life. Unraveling the complex mechanisms that regulate lung development is therefore essential for understanding the pathogenesis of developmental, genetic, and acquired lung disease. Progress is being made on elucidating the developmental mechanisms that regulate differentiation of the specific cell types that populate the lung. However, other areas of lung development are less well understood. For example, it is not known how the growth of progenitor cells and their differentiated progeny are coordinated to regulate the overall size and shape of the lung. These mechanisms are likely to involve biomechanical factors, such as differential pressure and stretch of lung epithelium and mesothelium; physical constraints imposed by the chest cavity; humoral factors that communicate the oxygen requirements of the organism to the developing lung (and chest cavity); and intrinsic genetic factors that have evolved to optimize lung architecture (branching pattern and alveolar surface area) for efficient physiological function.
To design and implement therapeutic strategies to induce lung growth and regeneration will require a comprehensive understanding of the identity of progenitor cells within epithelial and mesenchymal compartments of both the embryonic and postnatal lung. Manipulation of the growth and differentiation properties of lung progenitor cells will be important for both in vivo and in vitro therapeutic approaches to lung repair and for understanding homeostatic mechanisms that are essential to replace damaged cells. To repopulate damaged lung tissue in vivo or repopulate lung matrix scaffolds in vitro will require large numbers of cells. This will require understanding the mechanisms that regulate growth and differentiation of epithelial and mesenchymal progenitors into the specific cell types that populate the mature lung and devising methods to grow and differentiate these cells in vitro. The ultimate goal of lung developmental studies is to improve diagnosis of inherited and acquired disease and to learn how to therapeutically manipulate developmental programs to reestablish homeostasis, regenerate damaged or deficient cell populations, and eventually to generate functional replacement lung tissue in vitro for transplantation in vivo.
